About Global Demographics Healthcare

Specialists in helping health sector clients master their global markets



Who are we? | What we do? | Product overview

Who are we?

We are the health sector dedicated division of Global Demographics Ltd.

  • Global Demographics Healthcare Ltd is privately owned and registered as a Limited Liability Company in Hong Kong (where we started). Founded in 2003 as Asian Demographics Healthcare Ltd and changed to Global Demographics Healthcare Ltd in 2006. Global Demographics Ltd was founded in 1997.
  • Our team is experienced in epidemiology (study of the causes, distribution, and control of disease in populations), statistics, modeling, medicine and healthcare industry analysis.
  • Our clients range from large Pharmaceutical companies, medical device and biotechnology companies, to governments, Food & Beverage, and wellness companies who use our forecasts to help shape their strategy and help identify opportunities and threats for a specific product in time for effective action to be taken optimize their investments.
back to top

What do we do?

We provide Health Industry and Disease Market forecasts to 2030 for over 70 markets

We build proprietary models to forecast different aspects of the health industry for over 70 countries, through combining health and epidemiology parameters with demographic and socioeconomic factors. These forecasts range from epidemiology (disease or health condition), affordable market, price sensitivity to healthcare expenditure, macroeconomics and wellness, and help clients to master their market and optimize different stages of their business planning, whether new product entry, pricing, health economics, or R&D strategy etc.

Database Methodology

All the data in the extensive database can be traced back to the source documents as published by the governments of the markets covered, or in disease registries or recognized medical journals. Epidemiology and affordable market forecasts are derived through applying projected disease/ health condition rates to the forecasted population’s age gender profile to determine the likely number of cases (prevalence) by age/gender in the future. Using our affordability model, the number of prevalent cases who can afford treatment by different prices in the future is determined. More details of our unique approach can be found in the methodology.

back to top

Product Overview

Our forecasts are provided as 3 product lines:

ReportsInsights and analysis of key trends that will influence the health market or a specific disease/therapy market.
DatabasesBusiness planning, market situation analysis across markets, affordability levels.
Customized Therapy/Disease Market Forecast modelsCustomized interactive model to forecast affordable market & pricing sensitivity for a specific product

Please note

  • We collect secondary research data, stratify the data, ensure its validity, and use it to create our models and forecasts rather than conduct primary research.
  • We provide actual (historic) data from 2000 to 2008 and yearly forecasts from 2009 to 2030 for each geography.
  • We are data forecast providers and our products can be customized to the client’s needs. We can work with management consultancy companies by providing the relevant forecasts for the particular analysis or market research question being asked.
back to top